The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats

Journal Title: Turkish Journal of Obstetrics and Gynecology - Year 2019, Vol 16, Issue 1

Abstract

Objective: Asherman syndrome (AS) is a progressive disease involving menstrual disorders, recurrent pregnancy losses, and infertility developing as a result of partial or full blockade of the uterine cavity with adhesions. AS generally develops after trauma to the basal layer of the endometrium. In spite of a variety of methods such as adhesiolysis, inserting intrauterine devices, and administering high doses of estrogen, treatments remain insufficient. This study aimed to assess the effects of local intrauterine Ankaferd Blood Stopper (ABS) administration in inducing endometrial proliferation and building a normal endometrial layer in a rat model. Materials and Methods: AS was induced in 30 female Wistar albino rats. The rats were randomized into three groups: Group 1: AS group Group 2: AS + serum physiologic (SP) group Group 3: AS + ABS group AS model was induced in all animals. The uterine horns were harvested after 15 days of therapy and investigated for inflammation, fibrosis, and immunohistochemical (IHC) markers. Results: Compared with the other groups, fibrosis, and inflammation were significantly reduced in group 3 (chi-square, p=19.000, 0.001 and 26.365, <0.001, respectively). The IHC assessment showed that the tumor necrosis factor-α receptor levels were not different (Kruskal-Wallis H=0.091, p=0.995), but the interleukin (IL)-1β and IL-6 expression was reduced significantly in group 3 (H, p=18.706, <0.001, and 22.114, <0.001, respectively). Conclusion: The therapeutic effects of local administration of ABS in rats with AS model were demonstrated histopathologically and immunohistochemically. Based on these results, ABS administration in addition to the current treatments for AS may increase the treatment success and reduce the need for advanced treatment.

Authors and Affiliations

Başak Büyük, Fatma Beyazıt

Keywords

Related Articles

Associations between night eating syndrome and metabolic parameters in pregnant women

Objective: In this study, we aimed to evaluate the incidence of night eating in pregnancy and the relationship between night eating scores and nutritional status, insulin resistance, and lipid profile in pregnant women....

Neural and cardiac injury markers in fetal growth restriction and their relation to perinatal outcomes

Objective: To compare the levels of umbilical cord blood Neuron-Specific Enolase (NSE) and troponin T and venous blood gas samples between healthy newborns and growth-retarded fetuses with impaired Doppler velocity or lo...

Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

Objective: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cance...

The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats

Objective: Asherman syndrome (AS) is a progressive disease involving menstrual disorders, recurrent pregnancy losses, and infertility developing as a result of partial or full blockade of the uterine cavity with adhesion...

Laparoscopic hemi-hysterectomy in a noncommunicating uterine horn: The critical steps to be considered

Various congenital anomalies of the female tract such as agenesis, vertical or lateral fusion failure, and canalization failure occur when the normal development of the Müllerian duct disrupts in any stage of development...

Download PDF file
  • EP ID EP684581
  • DOI 10.4274/tjod.galenos.2018.21298
  • Views 200
  • Downloads 0

How To Cite

Başak Büyük, Fatma Beyazıt (2019). The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats. Turkish Journal of Obstetrics and Gynecology, 16(1), -. https://europub.co.uk/articles/-A-684581